Artelo Biosciences (OTC:ARTL) PERFORMANCE ANALYSIS IN FOCUS:
Net Income of the company is $-2623337. Net Income Available for Common Shareholders equals net income minus preferred dividends paid. Net income available to common shareholders are the profits remaining after the company pays all of its suppliers, employees, service providers, creditors, and preferred shareholders. In other words, this is revenue less all expenses and preferred dividends. The number measures common shareholders’ claim on the company’s cash flows.
Artelo Biosciences (OTC:ARTL) has performed -9.734513% around last month and performed -17.741935% over the last quarter. The stock showed return of 104% over five years and registered weekly return of 0.990099%. The stock has been watched at -56.595745% return throughout last twelve months.
Tracking last 52 weeks, the stock 52 week high price observed at $2.5 and 52 week low seen at $0.27. The 50 SMA is $1.077188 and 200 SMA is $1.216519. Moving averages can be used as support or resistance when a trader looks for a possible entry or exit in the market. This can also be said in the following way. In case the price makes a contact with the moving average on the price chart, the trader, examining closely this chart, will enter either into a long, or into a short position. Actually, this works in the same way as horizontal support or resistance lines. Moving averages are known as dynamic support and resistance, simply because they tend to change with prices.
Artelo Biosciences (OTC:ARTL) stock has changed $0.01 and moved 0.99% whereas stock price touched at $1.02 in last trading session. 2000 shares exchanged at hands while it’s an average volume stands with 385 shares. The company recorded relative volume of 5.19. When an analyst or an investor is researching a stock, it’s good to know what other investors think about it. After all, they might have some additional insight into the company or they might be creating a trend. Most popular methods for gauging market sentiment is to take a look at the recently traded volume.
EBITDA is $-2623057. EBITDA is a company’s earnings before interest, taxes, depreciation, and amortization and is an accounting measure calculated using a company’s net earnings, before interest expenses, taxes, depreciation and amortization are subtracted, as a proxy for a company’s current operating profitability.
Return on capital employed (ROCE) is 552.09%. Return on capital employed (ROCE) is a financial ratio that measures a company’s profitability and the efficiency with which its capital is used. Return on capital employed (ROCE) is the total amount of capital that a company has utilized in order to generate profits. It is the sum of shareholders’ equity and debt liabilities. It can be simplified as total assets minus current liabilities.
The current ratio is 0.257. The current ratio is the classic measure of liquidity. It indicates whether the business can pay debts due within one year out of the current assets. The quick ratio is 0.257. 1:1 shows the business can meet its current financial obligations with quick funds on hand. A ratio lower than 1:1 may indicate that the company relies too much on inventory or other assets to pay its short-term liabilities.
The debt/equity shows a value of 0.745. D/E Ratio is calculated by dividing a company’s total liabilities by its shareholder equity. In general, a high debt-to-equity ratio indicates that a company may not be able to generate enough cash to satisfy its debt obligations. However, low debt-to-equity ratios may also indicate that a company is not taking advantage of the increased profits that financial leverage may bring.
Volatility or average true range percent (ATRP 14) is 3.92%. The ATR expressed as a percentage of closing price. Average true range percent (ATRP) measures volatility on a relative level. ATRP allows securities to be compared whereas ATR does not. That means lower-priced stocks won’t necessarily have lower ATR values than higher-priced stocks. The stock beta value watched at 0.887. Beta measures the amount of market risk associated with market trade. High beta reveals more riskiness and low beta shows low risk.
Tracking profitability check, the firm profit margin which was recorded at 0.00% and operating margin noted at 0.00%. The Institutional ownership of the firm is 0.00% while Insiders ownership is 64.76%. The Company has been able to maintain return on asset (ROA) at -550.52% for the last twelve months. Return on equity (ROE) recorded at -1143.55%.
Headquarters Location of Artelo Biosciences (OTC:ARTL) is United States. P/B ratio is 76.47058. P/B is used to compare a stock’s market value to its book value. It has a market cap of $15588354. Using market capitalization to show the size of a company is important because company size is a basic determinant of various characteristics in which investors are interested, including risk.
Now The company has RSI figure of 46.14. RSI compares the magnitude of recent gains to recent losses to see if an asset is oversold or overbought. RSI is plotted on a scale of 0-100. Generally, if it is above 70, the stock is considered overbought and so one can look to sell it. Similarly, an RSI of less than 30 indicates the stock is oversold and can be bought.
ADX value listed at 40.4. ADX is best used for screening stocks and writing scans. By adding this indicator to your scanning software, you can eliminate all of the stocks that are in trading ranges. You can then set up your scan to find only those stocks that are in strong up trends or strong down trends.
So what is the ADX indicator good for?
The ADX indicator does not give buy or sell signals. It does, however, give you some perspective on where the stock is in the trend. Low readings and you have a trading range or the beginning of a trend. Extremely high readings tell you that the trend will likely come to an end.
David Culbreth – Category – Business
David Culbreth is a self-taught investor that has been investing in equities since she was a senior in college and continues to invest. He is extremely devoted to demystifying investing terminology for new investors.
David Culbreth is a senior author and journalist. He has more than 5 years of experience in institutional investment markets, including fixed income, equities, derivatives and real estate. David has a Bachelor in Business Administration with a major in Finance. He bought his first stocks in a private business at age 15 and made his first public stock trade at 23. He has always been interested in the stock market and how it behaves.
As the dad of two children, he’s made saving money and investing for them a high priority. Over many years of investing, he has made some wise choices and he’s made many mistakes. But he’s learned from both. Mr. David observations and experience give him the insight to stock market patterns and the investor behaviors that create them.